On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Corey J. Langer

ResearcherPublications, citations & collaboration network

Corey J. Langer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Corey J. Langer have?

ScholarIQindexed works

Corey J. Langer has 865 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Corey J. Langer have?

ScholarIQcitation count

Corey J. Langer has 40,142 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Corey J. Langer?

ScholarIQh-index

Corey J. Langer has an h-index of 90 in OpenAlex.

What is the i10-index of Corey J. Langer?

ScholarIQi10-index

Corey J. Langer has an i10-index of 338 in OpenAlex.

What is the ORCID of Corey J. Langer?

ScholarIQorcid

The ORCID for Corey J. Langer is on the source record.

What is the OpenAlex record for Corey J. Langer?

ScholarIQopenalex

The OpenAlex for Corey J. Langer is on the source record.

What are the most-cited papers on Corey J. Langer?

ScholarIQmost cited works
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
Walter J. Curran, Rebecca Paulus, Corey J. Langer, R. Komaki, Jong Seok Lee, Stephen L. Hauser, B. Movsas, Todd H. Wasserman, Seth A. Rosenthal, Elizabeth Gore, Mitchell Machtay, William T. Sause, James D. Cox
JNCI Journal of the National Cancer Institute. 20111,243 CitationsOPEN ACCESS
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge
Journal of Clinical Oncology. 2017585 CitationsOPEN ACCESS
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice T. Shaw, Glen J. Weiss, Meera Tugnait, Narayana I. Narasimhan, David J. Dorer, David Kerstein, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, David Ross Camidge
The Lancet Oncology. 2016352 Citations

Related on ScholarIQ

470M+ articles · free account